Iglesias LJ, Bernárdez ZI, Mundo MG, León ACE, Rendón MME

Language: Spanish
References: 11
Page: 15-21
PDF size: 98.75 Kb.

ABSTRACT

Objective. To assess the impact of implantation on anti-rotavirus vaccination in the care of children with diarrhea in hospital.
Material and methods. We conducted a prospective analysis in relation to the frequency and severity of the diarrheas episodes attending in a hospitality care; the frequency and severity of diarrheas episodes, before the introduction of vaccination, after its temporary suspension; and after its incorporation into the national immunization Schedule, were analyzed. In the last period, the severities for the diarrheas were analyzed in relation to anti-rotavirus immunization.
Results. For 2008-2010 (Official immunization), both cases rotavirus and no-rotavirus associated diarrheas reduced. The immunization to rotavirus reduced the risk of severity episodes’ (OR = 0.18, p = 0.01) only in child older than two years.
Conclusions. The rotavirus vaccination showed, in this natural assay, their impact to reduce the attendance cases and prevention of the severity forms.

REFERENCES

1. Granados GV, Velázquez DR, Salmerón J, Homedes N, Salinas EG, Morales CG. Burden of disease and cost of treating rotavirus diarrhea in Mexican children for the period 2001-2008. Vaccine 2011; 29(38): 6712-6719.

2. Velázquez FR. García LH, Rodriguez E, Cervantes Y, Gómez A, Melo M et al. Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease. Pediatr Infect Dis J 2004; 23(10): 149-155.

3. Ruiz PGM, Pérez SI, Velázquez FR, Abate H, Breuer T, Clemens SC et al. Human rotavirus vaccine study group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354(1): 11-22.

4. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter CS et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335(14): 1022-1028.

5. Linhares AC, Velázquez FR, Pérez SI, Sáez LX, Abate H, Espinoza F et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin America Infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008; 371(9619):1181-1189.

6. Centers for Disease Control and Prevention (CDC). Addition of history of intussusception as a contraindications for rotavirus vaccination. MMWR Morb Mortal Wkly Rep 2011; 60(41): 1427.

7. Ruska T, Vesikari T. Rotavirus disease in finnish children: use of numerical scores for clinical severity of diarrheal episodes. Scand J Infect Dis 1990; 22(3): 259-267.

8. Grimprel E, Garbag CA, Pircon JY, Curran D, Soriano GM, Meyer N. Surveillance to estimate the burden rotavirus gastroenteritis in children aged less than 3 years attending day care center in Paris, France. Hum Vaccin 2010; 6(5): 399-406.

9. Valencia MA, Bertozzi SM, Gutierrez JP, Itzier R. Cost-effectiveness of introducing a rotavirus vaccine in developing countries. The case of Mexico. BMC Infect Dis 2008; 8: 103.

10. Cairncross S, Hunt C, Boiddon S, Bosteon K, Curtis V, Fung IC et al. Water, sanitation and hygiene for the prevention of diarrhea. Int J Epidemiol 2010; 39(1): 193-205.

11. Constenia D, Velazquez FR, Rheingans RD, Antil L. Cervantes Y. Economic impact of a rotavirus vaccination program in Mexico. Rev Panam Salud Pub 2009; 25(6): 481-490.